Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 71 matching records.
71 results — page 1 of 3
- Level ASystematic ReviewPubMed
Adipose-Derived Stem Cells in Traumatic Brain Injury: A Systematic Review of Preclinical Studies.
Systematic Review on Neuroinflammation, published in Tissue Eng Regen Med (2026) — summary generated from the PubMed abstract.
- 2026
Tissue Eng Regen Med - Level DAnimal StudyPubMed
3D-bioprinted adipose-derived stem cell-secreted GAS6 + -sEVs reprogram microglia polarization and alleviate neuroinflammation in traumatic brain injury.
Animal Study on Neuroinflammation, Chronic Inflammation, published in J Nanobiotechnology (2026) — summary generated from the PubMed abstract.
- 2026
J Nanobiotechnology - Level DNarrative ReviewEurope PMC
Exosome-Based Diagnostics and Cell-Free Therapeutics for Traumatic Brain Injury: From Mechanisms to Bedside
Narrative Review, published in Int J Nanomedicine (2026) — summary generated from the PubMed abstract.
- 2026
Int J Nanomedicine1 citations - Level CProspective StudyPubMed
Autologous adipose-derived mesenchymal stromal cells for chronic traumatic brain injury.
Prospective Study on Neuroinflammation, published in Brain (2026) — summary generated from the PubMed abstract.
- 2026
Brain - Level DNarrative ReviewEurope PMC
The Design Strategies and Applications of Engineered Nanoparticles for Traumatic Brain Injury
Narrative Review on Face & Skin, published in Int J Nanomedicine (2026) — summary generated from the PubMed abstract.
- 2026
Int J Nanomedicine - Level AMeta-analysisEurope PMC
Neural stem cell transplantation in rodent models of traumatic brain injury: a systematic review and meta-analysis
Meta-analysis, published in Front Bioeng Biotechnol (2026) — summary generated from the PubMed abstract.
- 2026
Front Bioeng Biotechnol - Level DNarrative ReviewPubMed
Restoring neuroplasticity after CNS trauma: cell therapy approaches in spinal cord and traumatic brain injury.
Narrative Review on Spinal Cord Injury, published in J Transl Med (2026) — summary generated from the PubMed abstract.
- 2026
J Transl Med - Level CProspective StudyPubMed
Intranasal delivery of engineered extracellular vesicles promotes neurofunctional recovery in traumatic brain injury.
Prospective Study on Neuroinflammation, published in J Nanobiotechnology (2025) — summary generated from the PubMed abstract.
- 2025
J Nanobiotechnology20 citations - Level DNarrative ReviewPubMed
Apelin-13 can regulate adipose-derived mesenchymal stem cells to improve traumatic brain injury.
Narrative Review on Chronic Inflammation, published in Mol Cell Neurosci (2025) — summary generated from the PubMed abstract.
- 2025
Mol Cell Neurosci2 citations - Level DNarrative ReviewEurope PMC
Traumatic Brain Injury: Novel Experimental Approaches and Treatment Possibilities
Narrative Review on Face & Skin, published in Life (Basel) (2025) — summary generated from the PubMed abstract.
- 2025
Life (Basel)1 citations - Level DNarrative ReviewEurope PMC
Advances in research on biomaterials and stem cell/exosome-based strategies in the treatment of traumatic brain injury
Narrative Review, published in Acta Pharm Sin B (2025) — summary generated from the PubMed abstract.
- 2025
Acta Pharm Sin B4 citations - Level DAnimal StudyPubMed
Therapeutic effect of neural induced-stem cell-derived exosomes by regulating ERK/p38/NF-κB in traumatic brain injury.
Animal Study on Neuroinflammation, Chronic Inflammation, published in Biomed Pharmacother (2025) — summary generated from the PubMed abstract.
- 2025
Biomed Pharmacother - Level CProspective StudyPubMed
A Novel Human Stem Cell Culture Model for Severe Traumatic Brain Injury Reflecting Sexual Dimorphism in Heterotopic Ossification.
Prospective Study, published in Cells (2025) — summary generated from the PubMed abstract.
- 2025
Cells - Level DNarrative ReviewEurope PMC
Traumatic Brain Injury and Its Ophthalmologic Implications
Narrative Review on Back & Spine, Systemic / IV, published in Rom J Ophthalmol (2025) — summary generated from the PubMed abstract.
- 2025
Rom J Ophthalmol - Level DNarrative ReviewEurope PMC
Mesenchymal stem cell-derived extracellular vesicles as a cell-free therapy for traumatic brain injury via neuroprotection and neurorestoration
Narrative Review on Neuroinflammation, Chronic Inflammation, published in Neural Regen Res (2024) — summary generated from the PubMed abstract.
- 2024
Neural Regen Res29 citations - Level DNarrative ReviewEurope PMC
Role of regulatory non-coding RNAs in traumatic brain injury
Narrative Review, published in Neurochem Int (2024) — summary generated from the PubMed abstract.
- 2024
Neurochem Int16 citations - Level DAnimal StudyEurope PMC
Multimodal evaluation of the effects of low-intensity ultrasound on cerebral blood flow after traumatic brain injury in mice
Animal Study, published in BMC Neurosci (2024) — summary generated from the PubMed abstract.
- 2024
BMC Neurosci4 citations - Level DAnimal StudyPubMed
Evaluation of canine adipose-derived mesenchymal stem cells for neurological functional recovery in a rat model of traumatic brain injury.
Animal Study on Neuroinflammation, published in BMC Vet Res (2024) — summary generated from the PubMed abstract.
- 2024
BMC Vet Res2 citations - Level DAnimal StudyEurope PMC
Repeated intrathecal injections of peripheral nerve-derived stem cell spheroids improve outcomes in a rat model of traumatic brain injury
Animal Study on Scar, published in Stem Cell Res Ther (2024) — summary generated from the PubMed abstract.
- 2024
Stem Cell Res Ther4 citations - Level DAnimal StudyPubMed
Molecular intersections of traumatic brain injury and Alzheimer's disease: the role of ADMSC-derived exosomes and hub genes in microglial polarization.
Animal Study on Neuroinflammation, published in Metab Brain Dis (2024) — summary generated from the PubMed abstract.
- 2024
Metab Brain Dis - Level DNarrative ReviewEurope PMC
Traumatic brain injury and immunological outcomes: the double-edged killer
Narrative Review on Neuroinflammation, published in Future Sci OA (2023) — summary generated from the PubMed abstract.
- 2023
Future Sci OA14 citations - Level DAnimal StudyPubMed
Adipose-derived stem cell exosomes ameliorate traumatic brain injury through the NLRP3 signaling pathway.
Animal Study on Neuroinflammation, Chronic Inflammation, published in Neuroreport (2023) — summary generated from the PubMed abstract.
- 2023
Neuroreport13 citations - Level DAnimal StudyPubMed
Exosomes from ADSCs ameliorate nerve damage in the hippocampus caused by post traumatic brain injury via the delivery of circ-Scmh1 promoting microglial M2 polarization.
Animal Study on Neuroinflammation, published in Injury (2023) — summary generated from the PubMed abstract.
- 2023
Injury10 citations - Level DNarrative ReviewEurope PMC
Roles and therapeutic potential of different extracellular vesicle subtypes on traumatic brain injury
Narrative Review, published in Cell Commun Signal (2023) — summary generated from the PubMed abstract.
- 2023
Cell Commun Signal19 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406